Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic
  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Lyra Therapeutics, Inc. - Common Stock (NQ:LYRA)

1.520 -0.300 (-16.48%)
Streaming Delayed Price Updated: 3:59 PM EST, Feb 9, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 100,344
Open 1.830
Bid (Size) 1.520 (100)
Ask (Size) 1.820 (100)
Prev. Close 1.820
Today's Range 1.510 - 1.830
52wk Range 1.510 - 37.50
Shares Outstanding 31,836,815
Dividend Yield N/A

Performance

YTD
-51.9%
-51.9%
1 Month
-26.2%
-26.2%
3 Month
-65.5%
-65.5%
6 Month
-77.2%
-77.2%
1 Year
-84.2%
-84.2%

More News

Read More

Frequently Asked Questions

Is Lyra Therapeutics, Inc. - Common Stock publicly traded?
Yes, Lyra Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Lyra Therapeutics, Inc. - Common Stock trade on?
Lyra Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lyra Therapeutics, Inc. - Common Stock?
The ticker symbol for Lyra Therapeutics, Inc. - Common Stock is LYRA on the Nasdaq Stock Market
What is the current price of Lyra Therapeutics, Inc. - Common Stock?
The current price of Lyra Therapeutics, Inc. - Common Stock is 1.520
When was Lyra Therapeutics, Inc. - Common Stock last traded?
The last trade of Lyra Therapeutics, Inc. - Common Stock was at 02/09/26 03:59 PM ET
What is the market capitalization of Lyra Therapeutics, Inc. - Common Stock?
The market capitalization of Lyra Therapeutics, Inc. - Common Stock is 48.39M
How many shares of Lyra Therapeutics, Inc. - Common Stock are outstanding?
Lyra Therapeutics, Inc. - Common Stock has 48M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
 
 
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.